ONC

BeiGene
D

ONC

Arincen62/100B

BeiGene executives and insider trading

John V. Oyler sold 854,147 shares for 276.89M USD in 88 sales over the last twelve months, the last on 12 August 2026, and bought none on the open market.

Over the last twelve months BeiGene's insiders sold 1,023,825 shares for 332.55M USD in 166 sales on the open market, and bought 0 shares in 0 purchases.

Insiders over the last twelve months

Insider sales
166
Shares sold
1,023,825
Value sold
332.55M USD
Insider purchases
0

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
12.34M USD
0
3 months
48.49M USD
0
6 months
328.39M USD
0
1 year
332.55M USD
0
2 years
332.55M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
John V. Oyler CEOCo-Founder, Executive Chairman & Chief Executive Officer58854,147276.89M USD—12 Aug 2026—
Xiaodong Wang Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder63131,37046.84M USD—27 Oct 2026—
Chan Lee General Counsel, Senior VP & Corporate Secretary5813,4914.52M USD—5 Nov 2026—
Xiaobin Wu President and COO—5,0391.39M USD—25 Aug 2026—
Wang Lai President and Global Head of Research & Development494,3601.17M USD—23 Jun 2026—
Titus Ball Vice President & Chief Accounting Officer521,996759.62K USD—6 Nov 2026—
Aaron Rosenberg Chief Financial Officer491,788524.45K USD—3 Aug 2026—
Bros. Advisors Lp Baker Director—10,998261.98K USD—22 May 2026—
Margaret Dugan Director—21265.64K USD—22 May 2026—
Corazon (corsee) D. Sanders Director—21265.63K USD—22 May 2026—
Alessandro Riva Director—21265.62K USD—22 May 2026—

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
6 Nov 2026Titus BallSale1,533405.55621.71K USD26Form 4
6 Nov 2026Titus BallSale26406.3410.56K USD—Form 4
5 Nov 2026Chan LeeSale660400.00264.00K USD455Form 4
5 Nov 2026Chan LeeSale455402.00182.91K USD—Form 4
27 Oct 2026Xiaodong WangSale880355.56312.89K USD30,148Form 4
27 Oct 2026Xiaodong WangSale1,440355.62512.09K USD28,708Form 4
27 Oct 2026Xiaodong WangSale1,239357.54442.99K USD27,469Form 4
27 Oct 2026Xiaodong WangSale1,681358.75603.05K USD25,788Form 4
27 Oct 2026Xiaodong WangSale1,280359.72460.44K USD24,508Form 4
27 Oct 2026Xiaodong WangSale320360.64115.40K USD24,188Form 4
27 Oct 2026Xiaodong WangSale2,331362.35844.64K USD21,857Form 4
27 Oct 2026Xiaodong WangSale8,148363.242.96M USD13,709Form 4
27 Oct 2026Xiaodong WangSale2,841363.951.03M USD10,868Form 4
27 Oct 2026Xiaodong WangSale3,965365.431.45M USD6,903Form 4
27 Oct 2026Xiaodong WangSale6,903366.222.53M USD—Form 4

Common questions about BeiGene's executives and insiders

Source: Financial Modeling Prep